FindTrial
Sign In

Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00347841
Enrollment
Unknown
Registered
2006-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2007-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

To evaluate the IOP-lowering efficacy of bimatoprost 0.03% in patients found to be low-responders to latanoprost therapy.

Interventions

DRUGBimatoprost 0.03%, Latanoprost

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* · Male or female \> 18 years of age * Documented low-responder to latanoprost therapy as delineated in the outline above. * Diagnosis of open-angle glaucoma or ocular hypertension * Ability to provide informed consent and likely to complete all study visits

Exclusion criteria

* · Known contraindication to bimatoprost or any component of any study medication * Uncontrolled systemic disease * Active ocular disease other than glaucoma or ocular hypertension * Required use of ocular medications other than the study medications during the study (intermittent use of artificial tear solutions will be permitted) * History of intraocular surgery within the last 3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026